[Smoking cessation in coronary patients].
Smoking is one of the main risk factors for coronary artery disease and its complications, including sudden death. In smokers, smoking cessation is associated with improved 5-year outcome. Consequently, smoking cessation should be one of the main goals of the clinician in patients hospitalized for a coronary event. Any health professional has the capacity to deliver a simple message: "do you smoke?" and "are you willing to quit?". Such simple questions have a positive impact on the smoker who knows he has coronary artery disease. In addition nicotine substitutes and bupropion are particularly useful to help the patient: their efficacy has been demonstrated in several well-conducted studies. Last, treating tobacco smoking requires long-term follow-up of the patient who will be asked to consult regularly to this purpose.
Abdenbi
K
K
Centre cardiologique du nord, 32-36, rue des Moulins-Gémeaux, 93200 St-Denis, France.
D016642:Bupropion / Q000627:therapeutic use; D003324:Coronary Artery Disease / Q000517:prevention & control*; D003376:Counseling; D018765:Dopamine Uptake Inhibitors / Q000627:therapeutic use; D006801:Humans; D012307:Risk Factors; D016540:Smoking Cessation; D011795:Surveys and Questionnaires; D014029:Tobacco Use Disorder / Q000150:complications / Q000628:therapy
D018765:Dopamine Uptake Inhibitors; D016642:Bupropion